Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 13, 2021

SELL
$17.42 - $28.0 $229,944 - $369,600
-13,200 Closed
0 $0
Q1 2021

May 14, 2021

SELL
$20.22 - $26.73 $32,493 - $42,955
-1,607 Reduced 10.85%
13,200 $313,000
Q4 2020

Feb 02, 2021

BUY
$23.16 - $28.08 $2,223 - $2,695
96 Added 0.65%
14,807 $361,000
Q3 2020

Nov 05, 2020

BUY
$24.34 - $38.82 $93,100 - $148,486
3,825 Added 35.14%
14,711 $377,000
Q2 2020

Aug 12, 2020

BUY
$19.93 - $31.2 $216,957 - $339,643
10,886 New
10,886 $217,000

Others Institutions Holding ETNB

About 89bio, Inc.


  • Ticker ETNB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,484,500
  • Market Cap $417M
  • Description
  • 89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its lead product candidate is pegozafermin, a glycoPEGylated analog of fibroblast growth factor 21 for the treatment of nonalcoholic steatohepatitis. The company also int...
More about ETNB
Track This Portfolio

Track California Public Employees Retirement System Portfolio

Follow California Public Employees Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.